| Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients (NCT05074290) | University of Florida | 2023-03-30 |
| A Study of AP505 Injection in Patients With Advanced Malignant Solid Tumors (NCT06723964) | AP Biosciences Inc. | 2023-03-30 |
| A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers (NCT05737082) | Hanmi Pharmaceutical Company Limited | 2023-03-30 |
| A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia (NCT05759793) | Nanjing IASO Biotechnology Co., Ltd. | 2023-03-30 |
| A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2" (NCT06165237) | Boryung Pharmaceutical Co., Ltd | 2023-03-30 |
| HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors (NCT05360368) | Shanghai Henlius Biotech | 2023-03-30 |
| A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically (NCT05826600) | iOmx Therapeutics AG | 2023-03-30 |
| CPI-613 (Devimistat) in Combination With Modified FOLFIRINOX Plus Bevacizumab in Patients With Metastatic Colorectal Cancer (NCT05070104) | Cornerstone Pharmaceuticals | 2023-03-30 |
| Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults (NCT06827002) | University of Yaounde 1 | 2023-03-29 |
| Single Ascending Doses of HER-096 in Healthy Subjects (NCT05915247) | Herantis Pharma Plc. | 2023-03-29 |
| Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies (NCT05705505) | Traws Pharma, Inc. | 2023-03-29 |
| A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV) (NCT05830071) | Chiesi Farmaceutici S.p.A. | 2023-03-29 |
| First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors (NCT05759949) | Relay Therapeutics, Inc. | 2023-03-29 |
| AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease (NCT05791448) | University of Southern California | 2023-03-29 |
| Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma (NCT05703854) | M.D. Anderson Cancer Center | 2023-03-29 |
| Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT05719701) | Beijing InnoCare Pharma Tech Co., Ltd. | 2023-03-29 |
| Venetoclax Basket Trial for High Risk Hematologic Malignancies (NCT05292664) | Andrew E. Place, MD | 2023-03-29 |
| Clinical Trial to Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral Single Dose of JP-1366 Tablet in Healthy Volunteers (NCT05712681) | Onconic Therapeutics Inc. | 2023-03-29 |
| A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986278 in Healthy Chinese Participants (NCT05805904) | Bristol-Myers Squibb | 2023-03-29 |
| Aging and Reward System Response to Inflammation and Anxiety Study (NCT05363527) | University of California, Los Angeles | 2023-03-29 |
| Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid Tumors (NCT05718219) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2023-03-29 |
| A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers (NCT05830799) | Vicore Pharma AB | 2023-03-29 |
| Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT05768529) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2023-03-28 |
| Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer (NCT05735080) | Incyclix Bio | 2023-03-28 |
| Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma (NCT05546853) | University Hospital, Grenoble | 2023-03-28 |
| A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease (NCT05804383) | Allyx Therapeutics | 2023-03-28 |
| Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children (NCT04919109) | Codagenix, Inc | 2023-03-28 |
| A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058 (NCT05803850) | Guangzhou Henovcom Bioscience Co. Ltd. | 2023-03-28 |
| Clinical Trial With Local Decitabine Treatment of HPV-Induced VIN Grade 2/3 (DelVIN) (NCT05717621) | ViMREX GmbH | 2023-03-28 |
| Safety, Tolerability, and Pharmacokinetics of BAP5191 in Healthy Adults Following Topical Application of Repeat Doses (NCT05848453) | Bacoba AG | 2023-03-28 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adult Participants (NCT05791318) | Invivyd, Inc. | 2023-03-28 |
| A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors (NCT05821777) | Centessa Pharmaceuticals (UK) Limited | 2023-03-28 |
| Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy (NCT05694598) | Shanghai Vitalgen BioPharma Co., Ltd. | 2023-03-27 |
| A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors (NCT05718895) | Antengene Biologics Limited | 2023-03-27 |
| Pilot Study of Swift Microwave Device for Onychomycosis (NCT05674747) | Mediprobe Research Inc. | 2023-03-27 |
| Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation (NCT06050980) | Haisco Pharmaceutical Group Co., Ltd. | 2023-03-27 |
| Safety of Topical Insulin Drops for Open-angle Glaucoma (NCT04118920) | Centre hospitalier de l'Université de Montréal (CHUM) | 2023-03-27 |
| MSP3-CRM-Vac4All/ Alhydrogel® Vaccine (NCT05776017) | Vac4All | 2023-03-27 |
| A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants (NCT05788328) | Pfizer | 2023-03-27 |
| A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults (NCT05827068) | ModernaTX, Inc. | 2023-03-27 |
| Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State (NCT05739903) | Dong-A ST Co., Ltd. | 2023-03-25 |
| Mass Balance Study of [14C]ZSP1273 in Healthy Adult Male Subjects in China (NCT05873426) | Guangdong Raynovent Biotech Co., Ltd | 2023-03-25 |
| To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males (NCT05816356) | EpiDestiny, Inc. | 2023-03-24 |
| Overcoming Nicotine Dependence to Enable Quitting (NCT05513872) | Rush University Medical Center | 2023-03-24 |
| Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray (NCT06180083) | Humanis Saglık Anonim Sirketi | 2023-03-24 |
| A Study of XZB-0004 in Patients With Solid Tumors (NCT05772455) | Xuanzhu Biopharmaceutical Co., Ltd. | 2023-03-24 |
| A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Adult Non-Japanese and Japanese Participants (NCT06674941) | Amgen | 2023-03-24 |
| A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects (NCT05763459) | Calico Life Sciences LLC | 2023-03-24 |
| Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications (NCT05827614) | Boundless Bio, Inc. | 2023-03-24 |
| A Study to Assess the Food Effect and the Relative Bioavailability of the Cabotegravir (CAB) Pediatric Dispersible Tablet (DT) Formulation (NCT05776108) | ViiV Healthcare | 2023-03-23 |
| A Multiple-Dose Study of LY3493269 in Healthy Participants (NCT05794243) | Eli Lilly and Company | 2023-03-23 |
| A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies (NCT05669430) | GV20 Therapeutics | 2023-03-23 |
| A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine (NCT05750017) | Beijing Luzhu Biotechnology Co., Ltd. | 2023-03-23 |
| A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors (NCT05824455) | Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd. | 2023-03-23 |
| To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults (NCT05805826) | Pfizer | 2023-03-23 |
| A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma (NCT05440708) | Tvardi Therapeutics, Incorporated | 2023-03-23 |
| IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors (NCT05780307) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2023-03-23 |
| A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels (NCT05745727) | Protalix | 2023-03-23 |
| Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer (NCT05652868) | Mythic Therapeutics | 2023-03-23 |
| Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old (NCT05709288) | Institute of Hematology & Blood Diseases Hospital, China | 2023-03-23 |
| Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention (NCT05413551) | Stanford University | 2023-03-23 |
| Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin (NCT05915871) | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | 2023-03-23 |
| A Phase I Clinical Study of the Safety， Tolerability，Pharmacokinetics, and Initial Efficacy of HRS-6209 Monotherapy in Patients With Advanced Solid Tumors (NCT05781048) | Jiangsu HengRui Medicine Co., Ltd. | 2023-03-23 |
| Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors (NCT06056362) | Peking Union Medical College Hospital | 2023-03-23 |
| Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers (NCT05821387) | Quantum Biopharma | 2023-03-22 |
| Applying pGz in Mitochondrial Disease (NCT05569122) | Children's Hospital of Philadelphia | 2023-03-22 |
| The Formulation of Compound Phellinus Igniarius Decoction on Radiation Pneumonitis (NCT06861179) | Zhejiang Cancer Hospital | 2023-03-22 |
| Bioequivalence Study of Spironolactone Tablets in Healthy Subjects (NCT06579053) | SPH Sine Pharmaceutical Laboratories Co., Ltd. | 2023-03-22 |
| A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes (NCT06553248) | Gan and Lee Pharmaceuticals, USA | 2023-03-22 |
| Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310 (NCT05702450) | Keymed Biosciences Co.Ltd | 2023-03-22 |
| CARv3-TEAM-E T Cells in Glioblastoma (NCT05660369) | Marcela V. Maus, M.D.,Ph.D. | 2023-03-22 |
| KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma (NCT05723432) | Shanghai Kanda Biotechnology Co., Ltd. | 2023-03-22 |
| Safety & Immunogenicity of RVM-V001/RVM-V002 or RVMV001+RVMV002 (Co Administered as Separate Injections) in Healthy Individuals (NCT05788185) | RVAC Medicines (US), Inc. | 2023-03-22 |
| A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients (NCT05823285) | Qilu Pharmaceutical Co., Ltd. | 2023-03-22 |
| Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer (NCT05669482) | Verastem, Inc. | 2023-03-22 |
| First-in-Human Dose Escalation Study of AFM28 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT05817058) | Affimed GmbH | 2023-03-21 |
| QG101-23-0 Capsules SAD and MAD Study in Healthy Subjects (NCT05650528) | Amckaus PTY LTD. | 2023-03-21 |
| Promoting In-Home Activities at a Memory & Aging Clinic (NCT05771064) | University of Illinois at Chicago | 2023-03-21 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma (NCT05646836) | Genentech, Inc. | 2023-03-21 |
| Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis (NCT05802264) | Cystetic Medicines, Inc. | 2023-03-21 |
| A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis (NCT06491576) | Burgeon Therapeutics Co., Ltd. | 2023-03-21 |
| Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma (NCT05621096) | University of Nebraska | 2023-03-21 |
| Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD (NCT05614115) | University of Utah | 2023-03-21 |
| Study of CM326 Injection in Healthy Subjects (NCT05715333) | Keymed Biosciences Co.Ltd | 2023-03-21 |
| A Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD4059 in Healthy Subjects (NCT05653037) | Suzhou Ribo Life Science Co. Ltd. | 2023-03-21 |
| A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers (NCT05383170) | Cytovation AS | 2023-03-21 |
| A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes (NCT05794581) | Carmot Therapeutics, Inc. | 2023-03-21 |
| A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma (NCT05650632) | AbbVie | 2023-03-21 |
| Electrophysiological Effects of Potential QT Prolonging Drugs (NCT05716854) | Food and Drug Administration (FDA) | 2023-03-21 |
| HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor (NCT05787535) | HRYZ Biotech Co. | 2023-03-21 |
| MK-6194 Site of Injection Study in Healthy Adult Participants (MK-6194-013) (NCT06649877) | Merck Sharp & Dohme LLC | 2023-03-20 |
| Evaluation of the Value of 18F-Fluoromisonidazole (18F-FMISO) Positron Emission Tomography Hypoxia Imaging in Idiopathic Pulmonary Fibrosis (NCT05331729) | Centre Hospitalier Universitaire Dijon | 2023-03-20 |
| Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment (NCT05432804) | National Cancer Institute (NCI) | 2023-03-20 |
| The Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy Subject (NCT05737576) | Jiangsu HengRui Medicine Co., Ltd. | 2023-03-20 |
| Lentiviral Gene Therapy for p47 AR-CGD (NCT05207657) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2023-03-20 |
| Pharmacokinetics of Mitiperstat in Participants With Hepatic Impairment (NCT05751759) | AstraZeneca | 2023-03-20 |
| A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease (NCT05792163) | SciNeuro | 2023-03-20 |
| The Drug-drug Interaction of HSK16149 Capsule With Probenecid Tablets or Cimetidine Tablets in Healthy Subjects (NCT05881811) | Haisco Pharmaceutical Group Co., Ltd. | 2023-03-20 |
| ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer (NCT05650879) | Enliven Therapeutics | 2023-03-20 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects (NCT05740475) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2023-03-20 |